Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,813

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126

Nitric Oxide and Peroxynitrite in Health and Disease

Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

The Pathophysiology and Treatment of Sepsis

Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,134

NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease

Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819

Leukocyte-endothelial adhesion molecules

Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.bloodjournal8472068 · Cited by 2,687

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 453

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 435

Role of liver sinusoidal endothelial cells in liver diseases

Gracia‐Sancho, J., Caparrós, E., Fernández‐Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 436

Modulating the endocannabinoid system in human health and disease – successes and failures

Pacher, P., & Kunos, G. (2013) · FEBS Journal · doi:10.1111/febs.12260 · Cited by 418

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 351

Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay

Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F. J., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 320

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities

Bı́ró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.004 · Cited by 286

CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?

Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 266

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

Mukhopadhyay, P., Rajesh, M., Pan, H., Patel, V., Mukhopadhyay, B., Bátkai, S., Gao, B., Haskó, G., & Pacher, P. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.022 · Cited by 217

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death

Mukhopadhyay, P., Rajesh, M., Horváth, B., Bátkai, S., Park, O., Tanchian, G., Gao, R. Y., Patel, V., Wink, D. A., Liaudet, L., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.021 · Cited by 206

The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators

Félétou, M. (2011) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00031ed1v01y201105isp019 · Cited by 224

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

Mukhopadhyay, P., Rajesh, M., Bátkai, S., Patel, V., Kashiwaya, Y., Liaudet, L., Evgenov, O. V., Mackie, K., Haskó, G., & Pacher, P. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp369 · Cited by 199

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

Izzo, A. A., & Camilleri, M. (2008) · Gut · doi:10.1136/gut.2008.148791 · Cited by 197

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M. B., Mach, F., & Steffens, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.014 · Cited by 182

Endocannabinoids and traumatic brain injury

Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01343.x · Cited by 167

Role of the endocannabinoid system in diabetes and diabetic complications

Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13226 · Cited by 168

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

Murikinati, S. R., Jüttler, E., Keinert, T., Ridder, D. A., Muhammad, S., Waibler, Z., Ledent, C. A., Zimmer, A., Kalinke, U., & Schwaninger, M. (2009) · The FASEB Journal · doi:10.1096/fj.09-141275 · Cited by 157

Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

Choi, I.-Y., Ju, C., Jalin, A. M. A. A., Lee, D. I., Prather, P. L., & Kim, W.-K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.024 · Cited by 157

CB 1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

Mukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 156

Cannabinoid‐1 receptor activation induces reactive oxygen species‐dependent and ‐independent mitogen‐activated protein kinase activation and cell death in human coronary artery endothelial cells

Rajesh, M., Mukhopadhyay, P., Haskó, G., Liaudet, L., Mackie, K., & Pacher, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00712.x · Cited by 145

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner

Horváth, B., Mukhopadhyay, P., Kechrid, M., Patel, V., Tanchian, G., Wink, D. A., Gertsch, J., & Pacher, P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.014 · Cited by 143

Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice

Cao, Z., Mulvihill, M. M., Mukhopadhyay, P., Xu, H., Erdélyi, K., Hao, E., Holovac, E., Haskó, G., Cravatt, B. F., Nomura, D. K., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.028 · Cited by 144

The emerging role of the endocannabinoid system in cardiovascular disease

Pacher, P., & Steffens, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0145-8 · Cited by 142

Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists

Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 136

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion‐induced cardiomyopathy

Defer, N., Wan, J., Souktani, R., Escoubet, B., Perier, M., Caramelle, P., Manin, S., Deveaux, V., Bourin, M., Zimmer, A., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-129478 · Cited by 133

Targeting cannabinoid receptor CB2in cardiovascular disorders: promises and controversies

Steffens, S., & Pacher, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02042.x · Cited by 137

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 129

Modulation of the Endocannabinoid System in Cardiovascular Disease

Pacher, P., Mukhopadhyay, P., Rajesh, M., Godlewski, G., Bátkai, S., & Kunos, G. (2008) · Hypertension · doi:10.1161/hypertensionaha.105.063651 · Cited by 123

Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis

Servettaz, A., Kavian, N., Nicco, C., Deveaux, V., Chéreau, C., Wang, A., Zimmer, A., Lotersztajn, S., Weill, B. J., & Batteux, F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090763 · Cited by 119

A new cannabinoid CB2 receptor agonist HU‐910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

Horváth, B., Magid, L., Mukhopadhyay, P., Bátkai, S., Rajesh, M., Park, O., Tanchian, G., Gao, R. Y., Goodfellow, C. E., Glass, M., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01381.x · Cited by 112

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 111

Endocannabinoids and Traumatic Brain Injury

Mechoulam, R., & Shohami, E. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8008-6 · Cited by 111

Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor

Hudson, B. D., Hébert, T. E., & Kelly, M. E. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060251 · Cited by 112

Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations

Echeverria-Villalobos, M., Todeschini, A. B., Stoicea, N., Fiorda‐Diaz, J., Weaver, T. E., & Bergese, S. D. (2019) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2019.03.011 · Cited by 111

Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues

Gallelli, C. A., Calcagnini, S., Romano, A., Koczwara, J. B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A. M., Cassano, T., & Gaetani, S. (2018) · Antioxidants · doi:10.3390/antiox7070093 · Cited by 111

Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice

Verty, A. N. A., Stefanidis, A., McAinch, A. J., Hryciw, D. H., & Oldfield, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140592 · Cited by 103

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. J., Kong, W., Ganea, D., & Tuma, R. F. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9148-4 · Cited by 101

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality

Hwang, J., Adamson, C. L., Butler, D., Janero, D. R., Makriyannis, A., & Bahr, B. A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.003 · Cited by 100

Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator

Zhang, X., Maor, Y., Jf, W., Kunos, G., & Groopman, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00841.x · Cited by 99

A critical review of the cannabinoid receptor as a drug target for obesity management

Akbaş, F., Gasteyger, C., Sjödin, A. M., Astrup, A. V., & Larsen, T. M. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00520.x · Cited by 92

The endocannabinoid system as a target for the treatment of neuronal damage

Fernández‐Ruíz, J., García, C., Sagredo, O., Gómez‐Ruíz, M., & de Lago, E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003709792 · Cited by 89

Endocannabinoids in cerebrovascular regulation

Benyó, Z., Ruisanchez, É., Leszl-Ishiguro, M., Sándor, P., & Pacher, P. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00571.2015 · Cited by 87

Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway

Dhopeshwarkar, A., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232561 · Cited by 88

Interleukin-17 in post-stroke neurodegeneration

Swardfager, W., Winer, D. A., Herrmann, N., Winer, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.021 · Cited by 87

Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions

Ma, L., Jia, J., Niu, W., Jiang, T., Zhai, Q., Yang, L., Bai, F., Wang, Q., & Xiong, L. (2015) · Scientific Reports · doi:10.1038/srep12440 · Cited by 86

Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line

El‐Remessy, A. B., Rajesh, M., Mukhopadhyay, P., Horváth, B., Patel, V., Al-Gayyar, M. M. H., Pillai, B. A., & Pacher, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2061-4 · Cited by 83

Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic Options

Chen, G., Thakkar, M., Robinson, C. P., & Doré, S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00040 · Cited by 83

Physical and functional interaction between CB1cannabinoid receptors and β2‐adrenoceptors

Hudson, B. D., Hébert, T. E., & Kelly, M. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00681.x · Cited by 83

Endocannabinoids and the Heart

Hiley, C. R. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318192671d · Cited by 81

Modulation of cellular redox homeostasis by the endocannabinoid system

Lipina, C., & Hundal, H. S. (2016) · Open Biology · doi:10.1098/rsob.150276 · Cited by 80

Immune mechanisms in cerebral ischemic tolerance

García‐Bonilla, L., Benakis, C., Moore, J. M. R., Iadecola, C., & Anrather, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00044 · Cited by 86

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury

Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 80

Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules

Zhao, Y., Yuan, Z., Liu, Y., Xue, J., Tian, Y., Liu, W., Zhang, W., Shen, Y., Xu, W., Liang, X., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d2644d · Cited by 80

Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage

Petrucci, V., Chicca, A., Glasmacher, S., Pálóczi, J., Cao, Z., Pacher, P., & Gertsch, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09808-8 · Cited by 75

Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis

Li, Q., Wang, F., Zhang, Y.-M., Zhou, J., & Zhang, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350088 · Cited by 71

Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation

Vincent, L., Vang, D., Nguyen, J., Benson, B. A., Lei, J.-X., & Gupta, K. (2015) · Haematologica · doi:10.3324/haematol.2015.136523 · Cited by 68

CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis

Csóka, B., Németh, Z. H., Mukhopadhyay, P., Spolarics, Z., Rajesh, M., Federici, S., Deitch, E. A., Bátkai, S., Pacher, P., & Haskó, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006409 · Cited by 67

Cannabinoid-2 Receptor Activation Protects Against Infarct and Ischemia–Reperfusion Heart Injury

Wang, P., Jiang, L.-S., Bu, J., Huang, X.-J., Song, W., Du, Y.-P., & He, B. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182418997 · Cited by 67

Endocannabinoid involvement in endometriosis.

Dmitrieva, N., Nagabukuro, H., Resuehr, D., Zhang, G., McAllister, S. L., McGinty, K. A., Mackie, K., & Berkley, K. J. (2010) · Pain · doi:10.1016/j.pain.2010.08.037 · Cited by 64

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

Naidoo, V., Karanian, D. A., Vadivel, S. K., Locklear, J. R., Wood, J. T., Nasr, M. L., Quizon, P. M., Graves, E. E., Shukla, V. G., Makriyannis, A., et al. (2012) · Neurotherapeutics · doi:10.1007/s13311-011-0100-y · Cited by 60

Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation

Rajesh, M., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.159 · Cited by 60

Endocannabinoids and cardiac contractile function: Pathophysiological implications

Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 57

Phytocannabinoids and Endocannabinoids

Fišar, Z. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010051 · Cited by 57

Effect and mechanism of salvianolic acid B on the myocardial ischemia-reperfusion injury in rats

Xue, L., Wu, Z. F., Ji, X., Gao, X.-Q., & Guo, Y.-H. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60038-9 · Cited by 55

Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration

Wasserman, A. H., Venkatesan, M., & Aguirre, A. (2020) · Cells · doi:10.3390/cells9061391 · Cited by 50

Cannabinoid/agonist WIN 55,212‐2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS

González, C., Herradón, E., Abalo, R., Vera, G., Perez‐Nievas, B. G., Leza, J. C., Martin, M., & López‐Miranda, V. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1176 · Cited by 53

Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI

Xu, Z., Lv, X., Dai, Q., Ge, Y., & Xu, J. (2016) · Molecular Brain · doi:10.1186/s13041-016-0257-8 · Cited by 53

Predictors of malignant cerebral edema in cerebral artery infarction: A meta-analysis

Miao, J., Song, X., Sun, W., Qiu, X., Lan, Y., & Zhou, Z. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116607 · Cited by 52

Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils.

Zhang, Y.-B., Kan, M., Yang, Z.-H., Ding, W.-L., Yi, J., Chen, H.-Z., & Lu, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.070 · Cited by 47

Post‐ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death

Pellegrini-Giampietro, D. E., Mannaioni, G., & Bagetta, G. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06765.x · Cited by 50

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases

Pacher, P., & Gao, B. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00523.2007 · Cited by 51

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist

Hashiesh, H. M., Sharma, C., Goyal, S. N., Jha, N. K., & Ojha, S. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702675 · Cited by 52

Time‐Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator‐Activated Receptor Gamma (PPARγ)

O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2009) · PPAR Research · doi:10.1155/2009/425289 · Cited by 49

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction

Lim, S. Y., Davidson, S. M., Yellon, D. M., & Smith, C. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0034-2 · Cited by 49

An ultra-low dose of tetrahydrocannabinol provides cardioprotection

Waldman, M., Hochhauser, E., Fishbein, M., Aravot, D. J., Shainberg, A., & Sarne, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.014 · Cited by 48

Ischemia/reperfusion injury in liver resection: A review of preconditioning methods

Theodoraki, K. A., Tympa, A., Karmaniolou, I. I., Τsaroucha, A., Arkadopoulos, N. F., & Smyrniotis, V. E. (2011) · Surgery Today · doi:10.1007/s00595-010-4444-4 · Cited by 48

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold

Manera, C., Saccomanni, G., Malfitano, A. M., Bertini, S., Castelli, F., Laezza, C., Ligresti, A., Lucchesi, V., Tuccinardi, T., Rizzolio, F., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.031 · Cited by 48

Anandamide enhances expression of heat shock protein 72 to protect against ischemia–reperfusion injury in rat heart

Li, Q., Shi, M., & Li, B. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0228-5 · Cited by 47

Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists

Pascual, A. C., Martín-Moreno, A. M., Giusto, N. M., CEBALLOS, M. L. D., & Pasquaré, S. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.011 · Cited by 46

Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages

Lin, H., & Lee (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4815 · Cited by 46

Δ8‐Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors

Bátkai, S., Mukhopadhyay, P., Horváth, B., Rajesh, M., Gao, R. Y., Mahadevan, A., Mukkanti, A., Battista, N., Lichtman, A. H., Gauson, L. A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01410.x · Cited by 45

The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages

Hao, M., Jiang, L.-S., Fang, N., Pu, J., Hu, L., Shen, L., Song, W., & He, B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001511 · Cited by 45

The endocannabinoidome in neuropsychiatry: Opportunities and potential risks

Morris, G., Walder, K. R., Kloiber, S. M., Amminger, G. P., Berk, M., Bortolasci, C. C., Maes, M. H. J., Puri, B. K., & Carvalho, A. F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105729 · Cited by 48

Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain

Dowie, M. J., Grimsey, N. L., Hoffman, T., Faull, R. L. M., & Glass, M. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2014.06.004 · Cited by 44

CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat

Liu, Z., Wang, Y., Zhao, H., Zheng, Q., Xiao, L., & Zhao, M. (2014) · BioMed Research International · doi:10.1155/2014/971750 · Cited by 42

Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

Radaelli, D., Manfredi, A., Zanon, M., Fattorini, P., Scopetti, M., Neri, M., Frisoni, P., & D’Errico, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210412101929 · Cited by 42

Update on the Role of Cannabinoid Receptors after Ischemic Stroke

Capettini, L. D. S. A., Savergnini, S. Q., da Silva, R., Stergiopulos, N., Santos, R. A. S., Mach, F., & Montecucco, F. (2012) · Mediators of Inflammation · doi:10.1155/2012/824093 · Cited by 41

Targeting pain at its source in sickle cell disease

Gupta, K., Jahagirdar, O. B., & Gupta, K. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00021.2018 · Cited by 43

Prussian Blue Scavenger Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Inflammation and Reducing Oxidative Stress

Huang, Y., Xu, Q., Zhang, J., Yin, Y., Pan, Y., Zheng, Y., Cai, X., Xia, Q., & He, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891351 · Cited by 41

The role of the endocannabinoid system in liver diseases

Caraceni, P., Domenicali, M., Giannone, F. A., & Bernardi, M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.009 · Cited by 41

Cannabinoids in the Cardiovascular System

Ho, W. ‐. V., & Kelly, M. E. M. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.002 · Cited by 40

Activation of cannabinoid type 2 receptor protects skeletal muscle from ischemia-reperfusion injury partly via Nrf2 signaling

Zhang, M., Zhang, M., Wang, L., Yu, T.-S., Jiang, S., Jiang, P., Sun, Y., Pi, J., Zhao, R., & Guan, D.-W. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.056 · Cited by 39

Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage

Assaf, F., Fishbein, M., Gafni, M., Keren, O., & Sarne, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.005 · Cited by 40

Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury

Moradi, H., Oveisi, F., Khanifar, E., Moreno‐Sanz, G., Vaziri, N. D., & Piomelli, D. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0013 · Cited by 37

Therapeutical Potential of CB2 Receptors in Immune-Related Diseases

Leleu‐Chavain, N., Desreumaux, P., Chavatte, P., & Millet, R. (2014) · Current Molecular Pharmacology · doi:10.2174/1874467207666140219122337 · Cited by 37

Predicting futile recanalization, malignant cerebral edema, and cerebral herniation using intelligible ensemble machine learning following mechanical thrombectomy for acute ischemic stroke

Zeng, W., Li, W., Huang, K., Lin, Z., Dai, H., He, Z., Liu, R., Zeng, Z., Qin, G., Chen, W., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.982783 · Cited by 34

Role of CB 2 Receptor in the Recovery of Mice after Traumatic Brain Injury

Magid, L., Heymann, S., Elgali, M., Avram, L., Cohen, Y., Zaltsman, S. L., Mechoulam, R., & Shohami, E. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.6063 · Cited by 34

CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices

Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., & Pellegrini-Giampietro, D. E. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.021 · Cited by 33

The Role of CB1 and CB2 Cannabinoid Receptors in Myocardial Ischemia-Reperfusion Injury: Cardioprotective and Vasculoprotective Effects (a literature review)

Stepanov, I. V., Gorbunov, A. S., & Маслов, Л. Н. (2026) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2026-3133

Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury

Bátkai, S., Osei‐Hyiaman, D., Pan, H., El-Assal, O. N., Rajesh, M., Mukhopadhyay, P., Hong, F., Harvey-White, J. D., Jafri, A., Haskó, G., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7451com · Cited by 252

Cannabinoid-2 Receptor Activation Protects Against Infarct and Ischemia–Reperfusion Heart Injury

Wang, P., Jiang, L.-S., Bu, J., Huang, X.-J., Song, W., Du, Y.-P., & He, B. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182418997 · Cited by 67

Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart

Hajrasouliha, A. R., Tavakoli, S., Ghasemi, M., Maralani, P. J., Sadeghipour, H., Ebrahimi, F., & Dehpour, A. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.034 · Cited by 105

Cannabinoid CB1/CB2 Receptors in the Heart: Expression, Regulation, and Function

Kaschina, E. (2016) · InTech eBooks · doi:10.5772/62822 · Cited by 23